Results 71 to 80 of about 54,791 (206)

The Current Landscape and Future Prospects of Vaccine Manufacturing in Africa: Challenges, Innovations, and Opportunities: A Narrative Review

open access: yesHealth Science Reports, Volume 9, Issue 3, March 2026.
ABSTRACT Background and Aims Africa has significant challenges in meeting its vaccination needs, including inadequate manufacturing capacity, infrastructure deficiencies, a scarcity of experienced personnel, regulatory hurdles, restricted access to technology and intellectual property.
Courage Chandipwisa   +3 more
wiley   +1 more source

RC-IAL cell line: sensitivity of rubella virus grow

open access: yesRevista de Saúde Pública, 2000
OBJECTIVE: The rapid growth of the rubella virus in RC-IAL² with development of cytopathic effect, in response to rubella virus infection, is described. For purposes of comparison, the rubella virus RA-27/3 strain was titered simultaneously in the RC-IAL,
Figueiredo Cristina A   +6 more
doaj  

J Clin Virol [PDF]

open access: yes
BackgroundMany cases of Fuchs\u2019 uveitis have been associated with persistent rubella virus infection. A 73-year-old male patient with typical Fuchs\u2019 Uveitis Syndrome (FUS) first experienced heterochromia of the left eye at the age fourteen, when

core  

Clinical and Genetic Characteristics of Free Sialic Acid Storage Disorder

open access: yesJournal of Inherited Metabolic Disease, Volume 49, Issue 2, March 2026.
ABSTRACT Free sialic acid storage disorder (FSASD) is a lysosomal storage disorder that results from biallelic pathogenic variants in the SLC17A5 gene. This gene codes for sialin, a 12‐transmembrane domain protein that exports the charged sugar N‐acetylneuraminic acid (Neu5Ac; sialic acid) out of the lysosome.
Zoe Wolfenson   +18 more
wiley   +1 more source

Serological and Molecular Diagnosis of Rubella virus and Cytomegalovirus in aborted Patients in Al-Najaf province

open access: yesKufa Journal for Nursing Sciences, 2015
Background: Viral infections such as Rubella and Cytomegalovirus are feared risk during pregnancy. Rubella and Cytomegalovirus virus are fairly the respective major diagnostic issues in pregnancy, the laboratory diagnosis, and its rational use in ...
Baqur A. Sultan   +3 more
doaj   +1 more source

Trends and Patterns of Adverse Drug Reaction Reporting in Sierra Leone: A Retrospective Analysis of VigiFlow Data (2008–2022)

open access: yesPharmacoepidemiology and Drug Safety, Volume 35, Issue 3, March 2026.
ABSTRACT Purpose Adverse drug reactions (ADRs) present significant obstacles for healthcare systems, impacting both patient safety and the effectiveness of treatments. Despite this, there is a scarcity of research on ADR reports in Sierra Leone, especially over long periods.
Isatu Jalloh   +4 more
wiley   +1 more source

Достижения в элиминации кори и краснухи в Республике Беларусь

open access: yesЭпидемиология и вакцинопрофилактика, 2016
The analysis of measles and rubella surveillance data in Belarus for 2012 - 2015 was presented. Laboratory diagnosis based on revealing of specific IgM antibodies, dynamic of IgG concentration or detection of viral RNA.
E. O. Samoilovich   +4 more
doaj   +1 more source

Evaluation rubella susceptibility women aged 25-30 years in the Kharkiv region [PDF]

open access: yes, 2017
Актуальність проблеми краснухи у вагітних обумовлена появою синдрому вродженої краснухи (СВК), що складає біля 10 % від загального числа вроджених аномалій.
Семеренська, Т.І.
core  

Genetic correlations and clinical value of increased renal echogenicity in fetuses identified by prenatal ultrasonography

open access: yesPrecision Medical Sciences, Volume 15, Issue 1, Page 35-41, March 2026.
The corresponding images are as follows: enhanced fetal renal echo, enhanced fetal renal echo complicated with hydronephrosis, cardiac abnormality, chromosome microarray analysis: microdeletion of chromosome 17, whole‐exome sequencing: microdeletion of chromosome 17.
Haihong Liu   +4 more
wiley   +1 more source

STUDY OF NEUROVIRULENT PROPERTIES OF VACCINE AGAINST CULTURAL LIVE RUBELLA

open access: yesПедиатрическая фармакология, 2010
Experts at FSUE R&D Centre Microgen of the RF’s Healthcare Ministry have developed a national drug designed to prevent rubella — Cultural live vaccine against rubella on the basis of vaccinal strain RA 27/3.
A.N. Mironov   +5 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy